0001438133-20-000002.txt : 20200117
0001438133-20-000002.hdr.sgml : 20200117
20200117185735
ACCESSION NUMBER: 0001438133-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200116
FILED AS OF DATE: 20200117
DATE AS OF CHANGE: 20200117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANSEN BRIAN B
CENTRAL INDEX KEY: 0001542377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 20534700
MAIL ADDRESS:
STREET 1: 10210 GENETIC CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_157930543731668.xml
FORM 4
X0306
4
2020-01-16
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001542377
HANSEN BRIAN B
11075 ROSELLE ST
SAN DIEGO
CA
92121
0
1
0
0
EVP & CHIEF COMMERCIAL OFFICER
Common Stock
2020-01-16
4
M
0
10000
0
A
12991
D
Common Stock
2020-01-16
4
S
0
10000
69.762
D
2991
D
Stock Option
2.59
2020-01-16
4
M
0
10000
0
A
Common Stock
10000.0
0
D
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $69.76 and $69.77.
The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equalmonthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
/s/David Berger, Attorney-in-fact for Brian B. Hansen
2020-01-17